Cargando…

Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP

Impaired cardiorenal response to acute saline volume expansion in preclinical systolic dysfunction (PSD) may lead to symptomatic heart failure. The objective was to determine if combination phosphodiesterase-V inhibition and exogenous B-type natriuretic peptide (BNP) administration may enhance cardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wan, Siu-Hin, Torres-Courchoud, Isabel, McKie, Paul M., Slusser, Joshua P., Redfield, Margaret M., Burnett, John C., Hodge, David O., Chen, Horng H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	PRECLINICAL RESEARCH
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939015/ https://www.ncbi.nlm.nih.gov/pubmed/31909303 http://dx.doi.org/10.1016/j.jacbts.2019.08.008

Ejemplares similares

Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction
por: Wan, Siu‐Hin, et al.
Publicado: (2021)

Plant-derived extracellular vesicles (PDEVs) in nanomedicine for human disease and therapeutic modalities
por: Xu, Zhijie, et al.
Publicado: (2023)

The Vascular-Renal Connection in Patients Hospitalized With Hypertensive Crisis: A Population-Based Study
por: Wan, Siu-Hin, et al.
Publicado: (2018)

STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure
por: Cannone, Valentina, et al.
Publicado: (2021)

Novel Adult-Onset Systolic Cardiomyopathy Due to MYH7 E848G Mutation in Patient-Derived Induced Pluripotent Stem Cells
por: Yang, Kai-Chun, et al.
Publicado: (2018)

A Contemporary Systematic Approach to Assessing the Patient with Heart Failure with Reduced Ejection Fraction: Multimodal Noninvasive and Invasive Evaluation
por: Wan, Siu-Hin, et al.
Publicado: (2019)

Transcatheter Tricuspid Valve Implantation of NaviGate Bioprosthesis in a Preclinical Model
por: Navia, Jose L., et al.
Publicado: (2018)

Female Authorship in Preclinical Cardiovascular Research: Temporal Trends and Influence on Experimental Design
por: Labinaz, Alisha, et al.
Publicado: (2019)

Septal Reduction Using Transvenous Intramyocardial Cerclage Radiofrequency Ablation: Preclinical Feasibility
por: Shin, Eun-Seok, et al.
Publicado: (2020)

Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
por: Ma, Brigette B.Y., et al.
Publicado: (2009)

Stress vulnerability promotes an alcohol‐prone phenotype in a preclinical model of sustained depression
por: Riga, Danai, et al.
Publicado: (2018)

Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
por: Gelbert, Lawrence M., et al.
Publicado: (2014)

Mitral Butterfly: Preclinical Experience of a Novel Chordal Repair Device Using an Artificial Papillary Muscle
por: Ticar, Johanna M., et al.
Publicado: (2020)

Western Diet-Fed, Aortic-Banded Ossabaw Swine: A Preclinical Model of Cardio-Metabolic Heart Failure
por: Olver, T. Dylan, et al.
Publicado: (2019)

Abstract 26 The Role of Oxygen in Cord Blood Hematopoietic Stem and Progenitor Cell Expansion and Engraftment
por: Ropa, James, et al.
Publicado: (2023)

Abstract 28 A Novel Chemically Defined Culturing System to Support Hematopoietic Stem Cell Expansion
por: Uchiyama, Asako, et al.
Publicado: (2023)

MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975
por: Tang, Minhong, et al.
Publicado: (2022)

Progressive decline in circulating CNP with aging is associated with progressive cardiac fibrosis and myocardial impairment
por: Sangaralingham, Jeson, et al.
Publicado: (2009)

DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast cancer and is synergistic with anti-CTLA-4 immunotherapy
por: Bernier, Cynthia, et al.
Publicado: (2018)

Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy
por: Wardell, Suzanne E., et al.
Publicado: (2019)

Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic
por: Apostolatos, André H., et al.
Publicado: (2019)

M‐Atrial Natriuretic Peptide and Nitroglycerin in a Canine Model of Experimental Acute Hypertensive Heart Failure: Differential Actions of 2 cGMP Activating Therapeutics
por: McKie, Paul M., et al.
Publicado: (2014)

M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013)

Noninvasive Cardiovascular Imaging in Preclinical Research: Do We Get New Biomarkers Usable in Humans?
por: Kober, Frank
Publicado: (2023)

Propionate Alleviates Abdominal Aortic Aneurysm by Modulating Colonic Regulatory T-Cell Expansion and Recirculation
por: Yang, Fen, et al.
Publicado: (2022)

The degree of natriuretic peptide system activation in stable and high risk CHF characterized by increased cystatin C is not reflected in cGMP activation
por: Schirger, John A, et al.
Publicado: (2009)

The evaluation of the clinical utility of urocortin 1 and adrenomedullin versus proBNP in systolic heart failure
por: Yıldırım, Erkan, et al.
Publicado: (2017)

Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis
por: Morton, Jamie, et al.
Publicado: (2018)

Operator Independent Focused High Frequency ISM Band for Fat Reduction: Porcine Model
por: Weiss, Robert, et al.
Publicado: (2013)

MANP: a novel particulate guanylyl cyclase A receptor/cGMP activator for resistant hypertension: preliminary first in human clinical trial results
por: Burnett, John C, et al.
Publicado: (2015)

Cenderitide, a novel dual GC-A and GC-B receptor activator, is a potent chronic cardiorenal fibroinhibiting peptide which suppresses aldosterone and reduces proteinuria in models of ardiorenal fibrosis
por: Martin, Fernando L, et al.
Publicado: (2011)

Changes in Myocardial Microstructure and Mechanics With Progressive Left Ventricular Pressure Overload
por: Torres, William M., et al.
Publicado: (2020)

Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction
por: Luers, Claus, et al.
Publicado: (2010)

Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program
por: Bilous, Michael, et al.
Publicado: (2012)

Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction
por: AbouEzzeddine, Omar F., et al.
Publicado: (2017)

Mitral annular systolic velocity as a marker of preclinical systolic dysfunction among patients with arterial hypertension
por: Daskalov, Ivaylo Rilkov, et al.
Publicado: (2012)

Novel Junctophilin-2 Mutation A405S Is Associated With Basal Septal Hypertrophy and Diastolic Dysfunction
por: Quick, Ann P., et al.
Publicado: (2017)

Direct Immunochemiluminescent Assay for proBNP and Total BNP in Human Plasma proBNP and Total BNP Levels in Normal and Heart Failure
por: Nishikimi, Toshio, et al.
Publicado: (2013)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Britain may quit European atom study
por: McKie, R
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_lm2d7jre09ckf0v56ivv6f0d4a